Results 101 to 110 of about 9,220 (202)

Ruthenium Complexes of Atovaquone Acting on Multiple Stages of the <i>Plasmodium</i> Life Cycle. [PDF]

J Med Chem
Fabbri C, Marcon PHS, Santiago AS, Sousa CC, Quadros HC, de Sena Lamar Nunes L, de Menezes DDM, Santana RAG, Justiniano SCB, D'Alessandro S, Basilico N, Moreira DRM, de Araujo-Neto JH, Lopes SCP.   +13 more
europepmc   +1 more source

Tafenoquine: A Breakthrough Option for Babesiosis Treatment. [PDF]

Trop Med Infect Dis
Ma D, Zhou M, Cao S, Galon-Bedonia EM, Xu Z, Li C, Gao X, Xue S, Ji S.   +8 more
europepmc   +1 more source

Congenital babesiosis in China: first molecularly confirmed case of vertical transmission of Babesia microti. [PDF]

Emerg Microbes Infect
Liu J, Li D, Wang S, Gao S, Xu B, Zhao J, Liu Q, Chen M, Zhou X, Cai Y, He L.   +10 more
europepmc   +1 more source

Atovaquone-induced therapeutic rewiring of melanoma metabolism. [PDF]

J Invest Dermatol
Betancourt Ponce M, Heaton AR, Burkard SK, D'Amato A, Boonpattrawong N, Skala MC, Patankar M, Barroilhet L.   +7 more
europepmc   +1 more source

<i>Plasmodium falciparum</i> field isolates drug susceptibility in Mali. [PDF]

JAC Antimicrob Resist
Maiga FO, Dembele L, Dama S, Diakite O, Diallo F, Sogore F, Maiga M, Dao F, Dara N, Alhousseini ML, Traore OB, Djimde AA.   +11 more
europepmc   +1 more source

Clinical outcomes after switching from sulfamethoxazole-trimethoprim to atovaquone due to intolerance in patients with non-HIV Pneumocystis pneumonia: a single-center retrospective study. [PDF]

J Pharm Health Care Sci
Shirakawa Y, Nakano T, Sato K, Takahashi Y, Higashi M, Eguchi Y, Yamashina T, Ikeuchi T, Kaneshige S, Uchiyama M, Togawa A, Matsuo K, Kamimura H.   +12 more
europepmc   +1 more source

Atovaquone [PDF]

, 2020
openaire   +1 more source

A Pathogenic ROCK-Signaling Network Involving a Lysine Deletion in Myh11 Renders Carriers Susceptible to Aortic Dissection. [PDF]

Int J Mol Sci
Okuhata H, Tomida S, Ishima T, Nagai R, Aizawa K.   +4 more
europepmc   +1 more source

Efficacy and Safety of Antimalarial as Repurposing Drug for COVID-19 Following Retraction of Chloroquine and Hydroxychloroquine

Clinical Pharmacology: Advances and Applications
Irma Rahayu Latarissa,1,2 Miski Aghnia Khairinisa,1 Ghina Nadhifah Iftinan,2 Anna Meiliana,1,3 Ida Paulina Sormin,4,5 Melisa Intan Barliana,6,7 Keri Lestari1,2,7 1Department of Pharmacology and Clinical Pharmacy, Faculty of Pharmacy, Universitas ...
Latarissa IR, Khairinisa MA, Iftinan GN, Meiliana A, Sormin IP, Barliana MI, Lestari K   +6 more
doaj  

Novel heterospirocyclic antimalarials with activity against artemisinin- and multidrug-resistant P. falciparum malaria. [PDF]

Int J Parasitol Drugs Drug Resist
Theodoridis L, Giannangelo C, El-Saafin F, Prabhath MR, Macraild CA, Sharma P, Merino D, Creek DJ, Carvalho TG.   +8 more
europepmc   +1 more source